Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer

PHILADELPHIA, PA, June 04, 2024 (Korea Bizwire) – Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.  Antibody therapies called bispecific T cell engagers (BTEs) have emerged as effective treatments for some blood cancers [...]